 AUSTIN, Texas, March 4, 2021 PRNewswire -- Luminex Corporation NASDAQ: LMNX today announced that it has received Emergency Use Authorization EUA from the U.S. Food and Drug Administration FDA for a new expanded version of its NxTAG Respiratory Pathogen Panel RPP that includes... 